Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of novel N-benzylarylamide-dithiocarbamate based derivatives as dual inhibitors of tubulin polymerization and LSD1 that inhibit gastric cancers
Xin-Ying Yuan, Chun-Hong Song, Xiujuan Liu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 252, pp. 115281-115281
Closed Access | Times Cited: 17

Showing 17 citing articles:

Combination Therapy and Dual-Target Inhibitors Based on LSD1: New Emerging Tools in Cancer Therapy
Liang Shen, Bo Wang, ShaoPeng Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 922-951
Closed Access | Times Cited: 15
Design, synthesis and biological evaluation of 1,2,3-triazole benzothiazole derivatives as tubulin polymerization inhibitors with potent anti-esophageal cancer activities
Bowen Wu, Wenjing Huang, Yunhe Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116118-116118
Closed Access | Times Cited: 7
A review of progress in o-aminobenzamide-based HDAC inhibitors with dual targeting capabilities for cancer therapy
Weixin Zhang, Jiao Huang, Xin-Yi Tian, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115673-115673
Closed Access | Times Cited: 20
Overview of the epigenetic/cytotoxic dual-target inhibitors for cancer therapy
Hailiu Liang, Shuqing Li, Xiaopeng Peng, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117235-117235
Closed Access
Discovery of a selective and reversible LSD1 inhibitor with potent anticancer effects in vitro and in vivo
Xiaosong Zhang, Jin-Zhan Liu, Yadong Mei, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2025) Vol. 40, Iss. 1
Open Access
Tubulin degradation: Principles, agents, and applications
Yifan Zhang, Jiao Huang, Weixin Zhang, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106684-106684
Closed Access | Times Cited: 14
Research progress of LSD1-based dual-target agents for cancer therapy
Xiaojuan Yang
Bioorganic & Medicinal Chemistry (2024) Vol. 101, pp. 117651-117651
Closed Access | Times Cited: 2
N-Benzyl arylamide derivatives as novel and potent tubulin polymerization inhibitors against gastric cancers: Design, structure–activity relationships and biological evaluations
Jian Song, Shenghui Wang, Qiu-Ge Liu, et al.
Chinese Chemical Letters (2024) Vol. 36, Iss. 2, pp. 109678-109678
Closed Access | Times Cited: 2
Exploring the potential of histone demethylase inhibition in multi-therapeutic approaches for cancer treatment
Deping Li, Hailiu Liang, Yifei Wei, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115999-115999
Closed Access | Times Cited: 6
Discovery and optimization of 2,3-diaryl-1,3-thiazolidin-4-one-based derivatives as potent and selective cytotoxic agents with anti-inflammatory activity
Ahmed M. Shawky, Faisal A. Almalki, Ashraf N. Abdalla, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115712-115712
Closed Access | Times Cited: 5
Discovery of novel arylamide derivatives containing piperazine moiety as inhibitors of tubulin polymerisation with potent liver cancer inhibitory activity
Xiaoyi Shi, Jiao Huang, Jiakai Zhang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 4
Novel Acrylate-Based Derivatives: Design, Synthesis, Antiproliferative Screening, and Docking Study as Potential Combretastatin Analogues
Eman Fayad, Sarah Awwadh Altalhi, Matokah M. Abualnaja, et al.
ACS Omega (2023) Vol. 8, Iss. 41, pp. 38394-38405
Open Access | Times Cited: 4
Spectroscopic investigations, quantum chemical, molecular docking and drug likeness studies of t-butyl-3,4,5-trimethyl-2-pyrrole carboxylate
A. Bharathi, S. Jeyaseelan, Shamima Hussain, et al.
Journal of Molecular Structure (2023) Vol. 1295, pp. 136551-136551
Closed Access | Times Cited: 2
Verubulin (Azixa) Analogues with Increased Saturation: Synthesis, SAR and Encapsulation in Biocompatible Nanocontainers Based on Ca2+ or Mg2+ Cross-Linked Alginate
Kseniya N. Sedenkova, Denis N. Leschukov, Yuri K. Grishin, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1499-1499
Open Access | Times Cited: 2
Discovery of novel amide derivatives against VEGFR-2/tubulin with potent antitumor and antiangiogenic activity
Zhenling Liu, S.-Y. Mao, Huixia Li, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107679-107679
Closed Access
Design, synthesis and antitumor activity of novel 4-oxobutanamide derivatives
Caiju Wu, Jingliang He, Hanxue Li, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 113, pp. 129978-129978
Closed Access
Synthesis and antitumor evaluation of glycyrrhetinic acid‐dithiocarbamate hybrids
Jiahong Su, Xingyue Wang, Sha Li, et al.
Archiv der Pharmazie (2024) Vol. 358, Iss. 1
Closed Access
Page 1

Scroll to top